Showing 1,301 - 1,320 results of 101,153 for search '(( 3d point decrease ) OR ( 5 ((((wt decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.78s Refine Results
  1. 1301
  2. 1302
  3. 1303
  4. 1304
  5. 1305
  6. 1306
  7. 1307
  8. 1308

    Data_Sheet_1_Elevated temperature and decreased salinity impacts on exogenous Vibrio parahaemolyticus infection of eastern oyster, Crassostrea virginica.zip by Omario M. A. Ricketts (16450914)

    Published 2024
    “…Specifically, we examined whether an increase in water temperature and/or decrease in salinity would impair oyster resistance to V. parahaemolyticus, a human food and waterborne pathogen. …”
  9. 1309
  10. 1310

    Pharmacologically induced torpor by 5′-AMP does not decrease platelet count despite decreased body temperature. by Edwin L. de Vrij (550179)

    Published 2014
    “…<p>A) Pharmacologically induced torpor by 5′-AMP in mice does not decrease platelet count during torpor and shows an increase upon arousal. …”
  11. 1311
  12. 1312
  13. 1313
  14. 1314
  15. 1315

    Data Sheet 1_An autonomous navigation method for orchard mobile robots based on octree 3D point cloud optimization.docx by Hailong Li (216327)

    Published 2025
    “…However, the increased richness of information provided by 3D LiDAR also leads to a higher computational burden for point cloud data processing, posing challenges to real-time navigation. …”
  16. 1316

    Statistically significant union pathways refer to the miRNAs with a decreased expression on day 5. by Morgana Lüdtke Azevedo (15285409)

    Published 2023
    “…<p>Statistically significant union pathways refer to the miRNAs with a decreased expression on day 5.</p>…”
  17. 1317
  18. 1318
  19. 1319

    FAK, but not Pyk2 is required for GPVI-mediated ROS generation and platelet aggregation. A. by Naadiya Carrim (664456)

    Published 2014
    “…<p>Washed human platelets (2.5×10<sup>8</sup>/mL) preloaded with 10 µM H<sub>2</sub>DCFDA (for ROS experiments only) were pre-treated with vehicle control (0.1% DMSO), FAK inhibitor (1 µM PF-228), Pyk2 inhibitor (10 µM Tyrphostin A9) or Syk inhibitor (5 µM BAY), then stimulated with 1 µg/mL CRP and monitored for ROS generation (i) and platelet aggregation (ii). …”
  20. 1320